
Could immune system modulation be the next frontier in skincare?
Emerging research suggests that targeting immune pathways could offer novel strategies for managing chronic skin conditions, moving beyond symptomatic relief.
Intravenous Immunoglobulin for Dermatomyositis: What the Approval Evidence Shows
Intravenous immunoglobulin (IVIg) has received approval for dermatomyositis, with evidence showing its role in managing this rare autoimmune condition.
Medicare's APP pay parity proposal: Physician concerns laid bare
Physicians voiced significant concerns over a 2019 executive order proposing Medicare pay parity and supervision elimination for advanced practice providers.
A New Explanation for Excessive Sweating Points to Nerve Dysfunction
New research suggests that excessive sweating, or hyperhidrosis, may stem from a specific dysfunction in the sympathetic nervous system, rather than overactive sweat glands.
Peptide Therapies: Decoding Evidence from Topicals to Longevity
Peptide therapies show varied efficacy across indications, from established dermatological uses to investigational longevity applications. Clinicians must scrutinise the evidence for each specific peptide.
Litfulo Label Strengthened With New Alopecia Areata Safety Warnings
The European Medicines Agency has updated the product information for Litfulo, adding new warnings regarding serious adverse events for patients with alopecia areata.
FDA Rejects Galderma's RelabotulinumtoxinA for Second Time
Galderma's relabotulinumtoxinA received a second Complete Response Letter from the FDA, delaying its entry into the aesthetic market.
Paroxetine's Mechanism in Rosacea: Serotonin Pathway Clues
Paroxetine, a selective serotonin reuptake inhibitor, may modulate neurovascular dysregulation in rosacea via serotonin pathway interactions.
FDA Approves Skinvive for Facial Wrinkles, Including 'Tech Neck' Lines
The FDA has approved Skinvive, an injectable hyaluronic acid gel, for improving skin smoothness and reducing facial wrinkles, including those on the neck.